OBJECTIVE: To determine whether a specifically designed bispecific (Bcl-2/Bcl-xL) antisense oligonucleotide (ASO) induces apoptosis and enhances chemosensitivity in human prostate cancer LNCaP cells, as Bcl-2 and Bcl-xL are both anti-apoptotic genes associated with treatment resistance and tumour progression in many malignancies, including prostate cancer. MATERIALS AND METHODS: Inhibition of Bcl-2 and Bcl-xL expression by the bispecific ASO was evaluated using real-time reverse transcription-polymerase chain reaction and Western blotting, while growth inhibition and induction of apoptosis were analysed by a crystal violet assay, flow cytometry and Western blotting of apoptosis-relevant proteins. The effect of combined treatment with bispec...
Hormonally insensitive prostate cancer is a relatively slow-growing, but usually fatal, disease with...
Recent clinical studies have shown the promise of bcl-2 antisense therapy in patients with melanoma....
Journal Article; Research Support, Non-U.S. Gov't;Androgen-sensitive prostate cancer cells turn andr...
Background: Increased expression of the anti-apoptotic pro-teins Bcl-2 and Bcl-xL is involved in the...
Background: Increased expression of the anti-apoptotic proteins Bcl-2 and Bcl-xL is involved in the ...
Bcl-2 expression is upregulated in prostate cancer cells after androgen withdrawal and is associated...
<p>(<b>A</b>) Immunoblot presenting the expression level of the anti-apoptotic protein Bcl-2 in PC3 ...
Bcl-2 expression is upregulated in prostate cancer cells after androgen withdrawal and is associated...
Background and methods: Antisense oligonucleotides (oligos) have been employed against in vivo and i...
Bcl-2 expression is upregulated in prostate cancer cells after androgen withdrawal and is associated...
Antisense oligonucleotides (oligos) have been employed against in vivo and in vitro prostate cancer ...
Background: Antisense oligonucleotides (oligos) have been employed against in vivo and in vitro pros...
The B-cell lymphoma 2 (Bcl-2) family, comprised of pro- and anti-apoptotic proteins, regulates the d...
Background: Increased expression of the anti-apoptotic proteins Bcl-2 and Bcl-xL is involved in the ...
Background: Increased expression of the anti-apoptotic proteins Bcl-2 and Bcl-xL is involved in the ...
Hormonally insensitive prostate cancer is a relatively slow-growing, but usually fatal, disease with...
Recent clinical studies have shown the promise of bcl-2 antisense therapy in patients with melanoma....
Journal Article; Research Support, Non-U.S. Gov't;Androgen-sensitive prostate cancer cells turn andr...
Background: Increased expression of the anti-apoptotic pro-teins Bcl-2 and Bcl-xL is involved in the...
Background: Increased expression of the anti-apoptotic proteins Bcl-2 and Bcl-xL is involved in the ...
Bcl-2 expression is upregulated in prostate cancer cells after androgen withdrawal and is associated...
<p>(<b>A</b>) Immunoblot presenting the expression level of the anti-apoptotic protein Bcl-2 in PC3 ...
Bcl-2 expression is upregulated in prostate cancer cells after androgen withdrawal and is associated...
Background and methods: Antisense oligonucleotides (oligos) have been employed against in vivo and i...
Bcl-2 expression is upregulated in prostate cancer cells after androgen withdrawal and is associated...
Antisense oligonucleotides (oligos) have been employed against in vivo and in vitro prostate cancer ...
Background: Antisense oligonucleotides (oligos) have been employed against in vivo and in vitro pros...
The B-cell lymphoma 2 (Bcl-2) family, comprised of pro- and anti-apoptotic proteins, regulates the d...
Background: Increased expression of the anti-apoptotic proteins Bcl-2 and Bcl-xL is involved in the ...
Background: Increased expression of the anti-apoptotic proteins Bcl-2 and Bcl-xL is involved in the ...
Hormonally insensitive prostate cancer is a relatively slow-growing, but usually fatal, disease with...
Recent clinical studies have shown the promise of bcl-2 antisense therapy in patients with melanoma....
Journal Article; Research Support, Non-U.S. Gov't;Androgen-sensitive prostate cancer cells turn andr...